Ota Hisashi, Amino Nobuyuki, Morita Shinji, Kobayashi Kaoru, Kubota Sumihisa, Fukata Shuji, Kamiyama Naohisa, Miyauchi Akira
Kuma Hospital, Kobe, Japan.
Clin Endocrinol (Oxf). 2007 Jul;67(1):41-5. doi: 10.1111/j.1365-2265.2007.02832.x. Epub 2007 Apr 15.
Differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis is important for selection of proper therapy. It is, however, often difficult to make this distinction without measurement of radioactive iodine uptake. We investigated the possibility that assessment of thyroid blood flow would allow differentiation between the two entities.
One hundred and fourteen untreated patients with thyrotoxicosis (56 Graves' disease, 28 painless thyroiditis, 30 subacute thyroiditis) and 25 normal controls were examined. Serum levels of freeT4 (FT4), freeT3 (FT3) and TSH were measured by chemiluminescent immunoassay, and anti-TSH receptor antibodies (TSH-binding inhibitory immunoglobulin, TBII) were measured by enzyme-linked immunosorbent assay. Thyroid volume and blood flow (TBF) were measured quantitatively by ultrasonography.
TBF was significantly higher in Graves' disease (mean +/- 1SD: 14.9 +/- 6.4%, P < 0.0001) than in painless thyroiditis (0.8 +/- 0.5%), subacute thyroiditis (0.9 +/- 0.7%) and in normal controls (0.8 +/- 0.5%). All patients with Graves' disease had TBF values of more than 4% and all patients with painless thyroiditis and subacute thyroiditis had TBF values less than 4%. TBF values significantly correlated with values of radioactive iodine uptake (RAIU) either at 3 h (r = 0.492, P < 0.01) or 24 h (r = 0.762, P < 0.001) within the Graves' disease and painless thyroiditis groups. There was no relationship between TBF values and thyroid volumes or values of TBII in the Graves' disease group. All patients with Graves' disease had positive TBII of 15% or more. Three of 28 patients with painless thyroiditis and one of 30 patients with subacute thyroiditis had positive TBII.
TBF was quantitatively measured by power Doppler ultrasonography and was more effective than TBII for differentiation between destruction-induced thyrotoxicosis (painless or subacute thyroiditis) and Graves' thyrotoxicosis. TBF values of less than 4% in untreated thyrotoxic patients are laboratory signals of destruction-induced thyrotoxicosis and if these are determined, the radioactive iodine uptake test can be omitted for differential diagnosis of these two types of thyrotoxicosis.
区分破坏性甲状腺毒症和格雷夫斯甲状腺毒症对于选择合适的治疗方法很重要。然而,在不测量放射性碘摄取的情况下,往往很难做出这种区分。我们研究了评估甲状腺血流是否能够区分这两种疾病。
对114例未经治疗的甲状腺毒症患者(56例格雷夫斯病、28例无痛性甲状腺炎、30例亚急性甲状腺炎)和25例正常对照者进行了检查。采用化学发光免疫分析法测定血清游离T4(FT4)、游离T3(FT3)和促甲状腺激素(TSH)水平,采用酶联免疫吸附测定法测定抗促甲状腺激素受体抗体(促甲状腺激素结合抑制性免疫球蛋白,TBII)。通过超声检查定量测量甲状腺体积和血流(TBF)。
格雷夫斯病患者的TBF显著高于无痛性甲状腺炎患者(均值±1标准差:14.9±6.4%,P<0.0001)、亚急性甲状腺炎患者(0.8±0.5%)和正常对照者(0.8±0.5%)。所有格雷夫斯病患者的TBF值均超过4%,所有无痛性甲状腺炎和亚急性甲状腺炎患者的TBF值均低于4%。在格雷夫斯病组和无痛性甲状腺炎组中,TBF值与3小时(r = 0.492,P<0.01)或24小时(r = 0.762,P<0.001)的放射性碘摄取(RAIU)值显著相关。在格雷夫斯病组中,TBF值与甲状腺体积或TBII值之间无相关性。所有格雷夫斯病患者的TBII均为15%或更高。28例无痛性甲状腺炎患者中有3例、30例亚急性甲状腺炎患者中有1例TBII呈阳性。
通过能量多普勒超声对TBF进行定量测量,在区分破坏性甲状腺毒症(无痛性或亚急性甲状腺炎)和格雷夫斯甲状腺毒症方面比TBII更有效。未经治疗的甲状腺毒症患者TBF值低于4%是破坏性甲状腺毒症的实验室信号,如果确定了这些值,则可以省略放射性碘摄取试验以鉴别诊断这两种类型的甲状腺毒症。